State Street’s Dimension Therapeutics, Inc DMTX Stock Holding History

State Street’s Portfolio DMTX Stock Details DMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-16,100	Closed	-$97K	–	3819
2017 Q3	$97K	Hold	16,100	–	–	﹤0.01%	3635
2017 Q2	$23K	Sell	16,100 -169,944	-91%	-$231K	﹤0.01%	3649
2017 Q1	$323K	Sell	186,044 -500	-0.3%	-$1.33K	﹤0.01%	3447
2016 Q4	$812K	Buy	186,544 +50,570	+37%	+$269K	﹤0.01%	3320
2016 Q3	$1.09M	Buy	135,974 +25,249	+23%	+$183K	﹤0.01%	3172
2016 Q2	$665K	Buy	110,725 +45,200	+69%	+$344K	﹤0.01%	3351
2016 Q1	$513K	Buy	65,525 +20,700	+46%	+$163K	﹤0.01%	3346
2015 Q4	$506K	Buy	+44,825	New	+$567K	﹤0.01%	3340

State Street's DMTX Position: Q4 2017 in Review

State Street sold out of Dimension Therapeutics, Inc (DMTX) in Q4 2017, closing a stake of 16,100 shares — an estimated $97K sold.

State Street first reported a position in DMTX in Q4 2015 and held it in 8 quarters. The position peaked at $1.09M in Q3 2016. 0 funds tracked by Wall St. Rank hold DMTX as of Q4 2017.

State Street reported no remaining Dimension Therapeutics, Inc position as of Q4 2017 after selling out during the quarter.
State Street sold 16,100 Dimension Therapeutics, Inc shares in Q4 2017, an estimated $97K.
State Street first reported a position in Dimension Therapeutics, Inc in Q4 2015 and held it in 8 quarters.
State Street's Dimension Therapeutics, Inc position peaked at $1.09M in Q3 2016.
0 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q4 2017.

Based on State Street's 13F filing for Q4 2017, filed 14 Feb 2018.